Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with a focus on misleading statements regarding delinquency rates in private education loans [1][3]. Group 1: Class Action Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek appointment as lead plaintiff by February 17, 2026 [1]. - The lawsuit, titled Zappia v. SLM Corporation, claims that SLM and its executives made false statements and failed to disclose significant increases in early-stage delinquencies [3][4]. Group 2: Allegations and Impact - A report from TD Cowen on August 14, 2025, indicated that July 2025 delinquencies rose by 49 basis points month-over-month, contradicting SLM's CFO's earlier assurances about normal seasonal trends [4]. - Following the TD Cowen report, SLM's stock price dropped by approximately 8%, highlighting the market's reaction to the disclosed information [4]. Group 3: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows any investor who suffered losses during the class period to seek lead plaintiff status, which involves directing the lawsuit on behalf of all class members [5]. - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone, and is recognized for securing significant monetary relief in class action cases [6].

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Plug Power Inc. (NASDAQ: PLUG) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Plug Power securities between January 17, 2025 and November 13, 2025, both ...

Core Viewpoint - A class action lawsuit has been filed against Ramaco Resources, Inc. for alleged violations of federal securities laws during the Class Period from July 31, 2025, to October 23, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Ramaco securities during the specified Class Period [2]. - The complaint alleges that the defendants made materially false and misleading statements and failed to disclose adverse facts about the company's business and operations [3]. - Specific allegations include the failure to commence significant mining activity at the Brook Mine, lack of active work at the site, and overstated development progress, leading to misleading positive statements about the company's prospects [3]. Group 2: Next Steps for Investors - Investors wishing to join the lawsuit can review the complaint and are encouraged to contact the law firm by March 31, 2026, to request appointment as lead plaintiff [4]. - Participation in any recovery does not require serving as lead plaintiff [4]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful [5]. - The firm has a strong track record, having recovered hundreds of millions of dollars for investors in securities fraud cases [6].

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Richtech Robotics Inc. ("Richtech†or "the Company†) (NASDAQ: RR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. According to the Complaint, the Company made false and misleading statements to the market. Richtech falsely claimed to have a commerc ...

Core Viewpoint - Richtech Robotics Inc. is facing a class action lawsuit for allegedly misleading investors about its relationship with Microsoft, which has resulted in significant stock price declines [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Diez v. Richtech Robotics Inc. and is filed in the District of Nevada [1]. - The class period for the lawsuit is from January 27, 2026, to January 29, 2026, with a deadline of April 3, 2026, for investors to seek lead plaintiff status [1]. - The lawsuit alleges that Richtech Robotics falsely claimed a commercial relationship with Microsoft during the class period [3]. Group 2: Allegations and Impact - An article published by Hunterbrook Media on January 29, 2026, stated that Microsoft denied any partnership with Richtech Robotics, which led to a more than 29% drop in the company's Class B stock price over two trading days [4]. - The lawsuit claims that Richtech Robotics misrepresented its engagement with Microsoft as a commercial partnership when it was merely a standard customer engagement focused on AI solutions [4]. Group 3: Legal Representation and Process - Investors who purchased Richtech Robotics securities during the class period can seek to be appointed as lead plaintiff, representing the interests of all class members [5]. - The lead plaintiff will have the authority to select a law firm to litigate the case, and participation as lead plaintiff is not required to share in any potential recovery [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [6].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [4][5]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to between $1.840 billion and $1.854 billion, below previous estimates, and projected poor net sales growth of -2% to 2% for 2026. This led to a stock price drop of $35.22 per share, over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - A class action lawsuit has been filed against Fermi Inc. and its executives due to significant stock price drops linked to alleged violations of federal securities laws [1][3]. Company Overview - Fermi Inc. is an energy and AI infrastructure company focused on building large-scale nuclear reactors to support grid-independent data centers for AI companies [4]. - The company's flagship project is Project Matador, designed to provide dedicated power for AI workloads [4]. IPO and Allegations - Fermi completed its IPO in October 2025, claiming strong demand for Project Matador and securing a 20-year lease with an investment-grade-rated tenant [5]. - Allegations suggest that Fermi overstated tenant demand and misrepresented the agreement with the First Tenant [6]. Stock Price Impact - On December 12, 2025, Fermi's stock dropped by $5.16 per share, over 33%, following the termination of the Advance in Aid of Construction Agreement by the First Tenant [7].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - Following the Q3 2025 financial results on November 20, 2025, the company announced further cuts to its full year guidance and acknowledged that its strategy of pursuing adjacencies had not grown its total customer base, resulting in a stock price decline of $5.22, or 24.8%, from $21.04 to $15.82 per share [7]. Legal Proceedings - Investors have until March 16, 2026, to request to be appointed to lead the class action case, which is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al. [3].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][4]. Group 1: Lawsuit Details - The lawsuit is filed by Bleichmar Fonti & Auld LLP on behalf of investors in Ardent Health securities, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case, which is pending in the U.S. District Court for the Middle District of Tennessee [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Core Viewpoint - The BlackRock TCP Capital Corp. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with significant claims regarding the misrepresentation of its net asset value (NAV) and investment valuations during the specified class period [1][3]. Group 1: Class Action Details - The class action lawsuit is titled Burnell v. BlackRock TCP Capital Corp., and it allows purchasers of BlackRock TCP securities from November 6, 2024, to January 23, 2026, to seek appointment as lead plaintiff by April 6, 2026 [1]. - The lawsuit alleges that BlackRock TCP's NAV per share was $11.90 as of December 31, 2023, prior to the class period [2]. Group 2: Allegations Against BlackRock TCP - The lawsuit claims that BlackRock TCP made false or misleading statements regarding the timely valuation of its investments and the effectiveness of its portfolio restructuring efforts [3]. - It is alleged that BlackRock TCP's unrealized losses were understated, leading to an overstatement of its NAV [3]. Group 3: Impact on NAV and Stock Price - On February 27, 2025, BlackRock TCP reported that the number of portfolio companies on non-accrual status had more than doubled, resulting in a NAV decline of over 22% year-over-year to $9.23 per share, which led to a 9.6% drop in stock price [4]. - On January 23, 2026, BlackRock TCP disclosed that its NAV per share was actually between $7.05 and $7.09, representing a 19% decrease from the previous quarter and a 23.4% decrease from the prior year, causing the stock price to fall nearly 13% [5].